Costs of flexible sigmoidoscopy screening for colorectal cancer in the United Kingdom

International Journal of Technology Assessment in Health Care

Volumn 19, Issue 2, 2003, Pages 384-395

  Whynes, David K ^a   Frew, Emma J ^b   Edwards, Robert ^c   Atkin, Wendy S ^d  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c Cancer Research   (United Kingdom)

^d ST MARK S HOSPITAL   (United Kingdom)

Author keywords

Colorectal cancer; Cost; Flexible sigmoidoscopy; Screening

Indexed keywords

COSTS; DIAGNOSIS; ESTIMATION; TUMORS;

TECHNOLOGY ASSESSMENT;

HEALTH CARE;

ARTICLE; CANCER SCREENING; CLINICAL PROTOCOL; COLORECTAL CARCINOMA; COST BENEFIT ANALYSIS; HEALTH CARE COST; HEALTH CARE PLANNING; HEALTH CENTER; HEALTH SURVEY; HUMAN; HUMAN EXPERIMENT; MEDICAL AUDIT; SIGMOIDOSCOPY; UNITED KINGDOM;

EID: 0038016424     PISSN: 02664623     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0266462303000345     Document Type: Article

References (55)

1. Atkin WS, Cook C, Patel R, Edwards R. Variability of yield of neoplasia in average risk individuals undergoing flexible sigmoidoscopy screening. Gastroenterology. 2001;120(Suppl 1):A66.
2. Atkin WS, Cuzick J, Northover JMA, Whynes DK. Prevention of colorectal cancer by once-only sigmoidoscopy. Lancet. 1993;341:736-740.
3. Atkin WS, Edwards R, Wardle J, et al. Design of a multicenter randomised trial to evaluate flexible sigmoidoscopy in colorectal cancer screening. J Med Screen. 2000;8:137-144.
4. Atkin WS, Hart A, Edwards R, et al. Single blind, randomised trial of efficacy and acceptability of oral Picolax versus self administered phosphate enema in bowel preparation for flexible sigmoidoscopy screening. BMJ. 2000;320:1504-1509.
5. Atkin WS, Hart A, Edwards R, et al. Uptake, yield of neoplasia, and adverse effects of flexible sigmoidoscopy screening. Gut. 1998;42:560-565.
6. Atkin WS, Morson BC, Cusick J. Long-term risk of colorectal cancer after excision of rectosigmoid ademomas. N Engl J Med. 1992;326:658-662.
7. Bolin TD, Korman MG, Stanton R, et al. Positive cost effectiveness of early diagnosis of colorectal cancer. Colorectal Dis. 1999;1:113-122.
8. Coyle D, Drummond MF. Analyzing differences in the costs of treatment across centers within economic evaluations. Int J Technol Assess Health Care. 2001;17:155-163.
9. Cromwell DM, Moore RD, Brensinger JD, et al. Cost analysis of alternative approaches to colorectal screening in familial adenomatous polyposis. Gastroenterology. 1998;114:893-901.
10. Department of Health. Reference costs, 2000. Leeds: Department of Health; 2001.
11. Dove-Edwin I, Thomas HJW. Review article: The prevention of colorectal cancer. Aliment Pharmacol Ther. 2001;15:323-336.
12. Eddy D. Screening for colorectal cancer. Ann Intern Med. 1990;113:373-384.
13. Finkler SA. The distinction between cost and charges. Ann Intern Med. 1982;96:102-109.
14. Frazier AL, Colditz GA, Fuchs CS, Kuntz KM. Cost-effectiveness of screening for colorectal cancer in the general population. JAMA. 2000;284:1954-1961.
15. Frew E, Wolstenholme JL, Atkin WS, Whynes DK. Estimating time and travel costs incurred in clinic-based screening: Flexible sigmoidoscopy screening for colorectal cancer. J Med Screen. 1999;6:119-123.
16. Gazelle GS, McMahon PM, Scholz FJ. Screening for colorectal cancer. Radiology. 2000;215:327-335.
17. Geul KW, Bosman FT, van Blankenstein M, et al. Prevention of colorectal cancer: Costs and effectiveness of sigmoidoscopy. Scand J Gastroenterol. 1997;32(Suppl 223):79-87.
18. Helm JF, Russo MW, Biddle AK, et al. Effectiveness and economic impact of screening for colorectal cancer by mass fecal occult blood testing. Am J Gastroenterol. 2000;95:3250-3258.
19. Imperiale TF, Wagner DR, Ching YL, et al. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med. 2000;343:169-174.
20. International Agency for Research on Cancer. Cancer incidence, mortality and prevalence in the European Union, EUCAN 1997 estimates. Available at: www-dep.iarc.fr/eucan/eucan.htm. Accessed 2001.
21. Khandker RK, Dulski JD, Kilpatrick JB, et al. A decision model and cost-effectiveness analysis of colorectal cancer screening and surveillance guidelines for average-risk adults. Int J Technol Assess Health Care. 2000;16:799-810.
22. Levin B, Murphy GP. Revision in American Cancer Society recommendations for the early detection of colorectal cancer. CA Cancer J Clin. 1992;42:296-299.
23. Levin TR, Palitz A, Grossman S, et al. Predicting advanced proximal colonic neoplasia with screening sigmoidoscopy. JAMA. 1999;281:1611-1617.
24. Lewis JD, Asch DA. Barriers to office-based screening sigmoidoscopy: Does reimbursement cover costs? Ann Intern Med. 1999;130:525-530.
25. Lewis JD, Brown A, Localio R, Schwartz S. Initial evaluation of rectal bleeding in young persons: A cost-effectiveness analysis. Ann Intern Med. 2002;136:99-110.
26. Lieberman D. Mass screening: North American perspective. In: Young GP, Rozen P, Levin B, eds. Prevention and early detection of colorectal cancer. London: WB Saunders Company Ltd; 1996:289-300.
27. Lieberman D, Weiss DG, for the Veterans Affairs Cooperative Study Group 380. One-time screening for colorectal cancer with combined fecal occult blood testing and examination of the distal colon. N Engl J Med. 2001;345:555-560.
28. Lieberman DA. Cost-effectiveness of colon cancer screening. Gastroenterology. 1995;109:1781-1790.
29. Loeve F, Brown ML, Boer R, et al. Endoscopic colorectal cancer screening: A cost-saving analysis. J Natl Cancer Inst. 2000;92:557-563.
30. Marshall JR, Fay D, Lance P. Potential costs of flexible sigmoidoscopy-based colorectal cancer screening. Gastroenterology. 1996;111:1411-1417.
31. Mulcahy HE, Farthing MJG, O'Donoghue DP. Fortnightly review: Screening for asymptomatic cancer. BMJ. 1997;314:285-291.
32. Neugut AI, Young GP. Screening for colorectal cancer: An overview. In: Young GP, Rozen P, Levin B, eds. Prevention and early detection of colorectal cancer. London: WB Saunders Company Ltd; 1996:357-367.
33. Newcomb PA, Norfleet RG, Storer BE, et al. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst. 1992;84:1572-1575.
34. Norum J. Prevention of colorectal cancer: A cost-effectiveness approach to a screening model employing sigmoidoscopy. Ann Oncol. 1998;9:613-618.
35. Pathmakanthan S, Murray I, Smith K, et al. Nurse endoscopists in United Kingdom health care: A survey of prevalence, skills and attitudes. J Adv Nurs. 2001;36:705-710.
36. Redelmeier DA, Bell CM, Detsky AS, Pansegrau GK. Charges for medical care at different hospitals. Arch Intern Med. 2000;160:1417-1422.
37. Rex DK, Lehman GA, Ulbright TM, et al. The yield of a second screening sigmoidoscopy in average risk persons after one negative examination. Gastroenterology. 1994;106:593-595.
38. Rozen P, Ron E. A cost analysis of screening methodology for family members of colorectal cancer patients. Am J Gastroenterol. 1989;12:1548-1551.
39. Schoenfeld P, Lipscomb S, Crook J, et al. Accuracy of polyp detection by gastroenterologists and nurse endoscopists during flexible sigmoidoscopy: A randomized trial. Gastroenterology. 1999;117:486-489.
40. Selby JV, Friedman GD, Quesenberry CP, Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med. 1992;326:653-657.
41. Shaheen NJ, Crosby MA, O'Malley MS, et al. The practices and attitudes of primary care nurse practitioners and physician assistants with respect to colorectal cancer screening. Am J Gastroenterol. 2000;95:3259-3265.
42. Sonnenberg A, Delco F, Inadomi JM. Cost-effectiveness of colonoscopy in screening for colorectal cancer. Ann Intern Med. 2000;133:573-584.
43. Stewart BT, Keck JO, Duncan AV, et al. Difficult or incomplete flexible sigmoidoscopy: Implications for a screening programme. Aust N Z J Surg. 1999;69:19-21.
44. Suleiman S, Sonnenberg A. Cost-effectiveness of endoscopy in irritable bowel syndrome. Arch Intern Med. 2001;161:369-375.
45. Theuer CP, Wagner JL, Taylor TH, et al. Racial and ethnic colorectal cancer patterns affect the cost-effectiveness of colorectal cancer screening in the United States. Gastroenterology. 2001;120:848-856.
46. UK Flexible Sigmoidoscopy Trial Investigators. Single flexible sigmoidoscopy screening to prevent colorectal cancer: Baseline findings of a UK multicenter trial. Lancet. 2002;359:1291-1300.
47. Vijan S, Hwang EW, Hofer TP, Hayward RA. Which colon cancer screening test? A comparison of costs, effectiveness and compliance. Am J Med. 2001;111:593-601.
48. Wagner JL, Herdman RC, Wadhwa S. Cost effectiveness of colorectal cancer screening in the elderly. Ann Intern Med. 1991;115:807-817.
49. Walker AR, Whynes DK, Chamberlain JO, Hardcastle JD. The cost of screening for colorectal cancer. J Epedemiol Community Health. 1991;45:220-224.
50. Walker AR, Whynes DK, Hardcastle JD, Chamberlain JO. The hospital costs of diagnostic procedures for colorectal cancer. J Clin Epidemiol. 1991;44:907-914.
51. Wallace MB, Kemp JA, Meyer F, et al. Screening for colorectal cancer with flexible sigmoidoscopy by nonphysician endoscopists. Am J Med. 1999;107:214-218.
52. Whynes DK. Cost-effectiveness of fecal occult blood screening for colorectal cancer: Results of the Nottingham trial. Crit Rev Oncol Hematol. 1999;32:155-165.
53. Whynes DK, Neilson AR, Walker AR, Hardcastle JD. Fecal occult blood screening for colorectal cancer: Is it cost-effective? Health Econ. 1998;7:21-29.
54. Winawer SJ, Zauber AG, O'Brien MJ, et al. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. N Engl J Med. 1993;328:901-906.
55. Young GP, Macrae FA, St John DJB. Clinical methods for early detection: Basis, use and evaluation. In: Young GP, Levin B, editors. Prevention and early detection of colorectal cancer. London: WB Saunders Company Ltd; 1996:242-270.